Recognised for its ‘strong track record of great results’,
Latham & Watkins LLP’s team advises household names on complex, multi-patent and high-value patent litigation cases. As well as its market-leading pharmaceutical and life sciences patent practice, the ’extremely sharp’ department has been growing a major technology offering for technology giants such as Netflix and Taiwan Semiconductor Manufacturing Corporation. The team demonstrates experience in all key litigation avenues, including the ITC and PTAB.
David P. Frazier, from Washington DC, is a stand-out practitioner renowned for defending cutting-edge pharmaceutical products against infringing biosimilars. Frazier co-heads the department with
Jennifer Barry, based in San Diego, and Austin’s Jeff Homrig. In Washington, DC,
Gabriel K. Bell specializes in patent litigation in the Federal Circuit and District Courts. In New York City,
Rachel Renee Blitzer, who was promoted to partnership in March 2024, focuses on complex patent and trade secret cases involving technologies, machinery, and medical devices. Douglas Lumish is well-regarded for his exceptional patent litigation record, and practices from the Bay Area.
Maximilian Grant retired in December 2024.